HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?

heat shock protein 90 histone deacetylase 6 inhibitor imatinib resistance leukemia stem cells personalized treatment targeted therapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
29 Jan 2020
Historique:
received: 06 01 2020
revised: 23 01 2020
accepted: 27 01 2020
entrez: 5 2 2020
pubmed: 6 2 2020
medline: 6 2 2020
Statut: epublish

Résumé

Imatinib became the standard treatment for chronic myeloid leukemia (CML) about 20 years ago, which was a major breakthrough in stabilizing the pathology and improving the quality of life of patients. However, the emergence of resistance to imatinib and other tyrosine kinase inhibitors leads researchers to characterize new therapeutic targets. Several studies have highlighted the role of histone deacetylase 6 (HDAC6) in various pathologies, including cancer. This protein effectively intervenes in cellular activities by its primarily cytoplasmic localization. In this review, we will discuss the molecular characteristics of the HDAC6 protein, as well as its overexpression in CML leukemic stem cells, which make it a promising therapeutic target for the treatment of CML.

Identifiants

pubmed: 32013157
pii: cancers12020318
doi: 10.3390/cancers12020318
pmc: PMC7072136
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Cell Sci. 2016 Jan 1;129(1):9-16
pubmed: 26729027
Mol Cancer. 2018 Feb 19;17(1):49
pubmed: 29455643
Bioorg Med Chem. 2008 Feb 15;16(4):2011-33
pubmed: 18054239
Biochim Biophys Acta Mol Cell Res. 2019 Jun;1866(6):992-1003
pubmed: 30867138
Oncotarget. 2017 Jan 10;8(2):2694-2707
pubmed: 27926524
Eur J Cancer. 2018 Nov;104:9-20
pubmed: 30296736
J Biol Chem. 2005 Jul 22;280(29):26729-34
pubmed: 15937340
Chem Commun (Camb). 2016 Feb 21;52(15):3219-22
pubmed: 26810607
Oncogene. 2016 Mar 24;35(12):1517-28
pubmed: 26119938
J Hematol Oncol. 2017 Feb 18;10(1):50
pubmed: 28214467
Sci Signal. 2012 Jun 19;5(229):ra45
pubmed: 22715468
EMBO J. 2002 Dec 16;21(24):6820-31
pubmed: 12486003
J Med Chem. 2013 Sep 12;56(17):6775-91
pubmed: 23905680
Proc Natl Acad Sci U S A. 2015 Sep 29;112(39):12005-10
pubmed: 26371309
Ann Hematol. 2019 Feb;98(2):533-535
pubmed: 30032412
Curr Top Med Chem. 2016;16(7):745-76
pubmed: 26303418
Lancet Oncol. 2007 Nov;8(11):1018-29
pubmed: 17976612
EMBO J. 2012 Feb 15;31(4):856-69
pubmed: 22193721
ACS Med Chem Lett. 2019 Jul 05;10(8):1122-1127
pubmed: 31413795
J Biol Chem. 2011 Mar 18;286(11):9280-6
pubmed: 21220424
Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):515-29
pubmed: 23890944
Blood. 2006 Jun 15;107(12):4888-97
pubmed: 16497976
J Med Chem. 2008 Jul 10;51(13):3985-4001
pubmed: 18558669
J Med Chem. 2013 Feb 28;56(4):1772-6
pubmed: 23368884
J Med Chem. 2014 Oct 9;57(19):8026-34
pubmed: 25238284
J Med Chem. 2015 May 28;58(10):4325-38
pubmed: 25906087
Cancer Res. 1993 Aug 1;53(15):3603-10
pubmed: 8339266
Pain. 2017 Jun;158(6):1126-1137
pubmed: 28267067
J Med Chem. 2019 Feb 14;62(3):1138-1166
pubmed: 30645113
Cell. 2007 Jan 26;128(2):269-80
pubmed: 17254966
Cancer Biol Ther. 2014 Jul;15(7):951-62
pubmed: 24759597
Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9633-8
pubmed: 18606987
J Biol Chem. 2004 Nov 12;279(46):48246-54
pubmed: 15347674
Biomol Detect Quantif. 2017 Feb 14;11:4-20
pubmed: 28331814
Nat Rev Clin Oncol. 2020 Feb;17(2):91-107
pubmed: 31570827
EMBO J. 2005 Oct 19;24(20):3532-42
pubmed: 16193064
J Am Chem Soc. 2010 Aug 11;132(31):10842-6
pubmed: 20614936
J Biol Regul Homeost Agents. 2018 Jul-Aug;32(4):851-858
pubmed: 30043566
Drug Des Devel Ther. 2016 Oct 13;10:3355-3361
pubmed: 27784993
Nat Rev Clin Oncol. 2016 Jul;13(7):431-46
pubmed: 27030078
J Immunol. 2002 Nov 15;169(10):5441-50
pubmed: 12421919
J Biol Chem. 2015 May 29;290(22):14045-56
pubmed: 25873389
Trends Biochem Sci. 2015 Aug;40(8):435-45
pubmed: 26067716
Biochem J. 2003 Mar 15;370(Pt 3):737-49
pubmed: 12429021
ACS Med Chem Lett. 2015 Oct 05;6(11):1156-61
pubmed: 26617971
N Engl J Med. 2003 Oct 9;349(15):1451-64
pubmed: 14534339
Int J Cancer. 2019 Aug 1;145(3):735-747
pubmed: 30694564
Protein Cell. 2015 Jan;6(1):42-54
pubmed: 25311840
EMBO J. 2011 Aug 16;30(20):4142-56
pubmed: 21847094
J Med Chem. 2013 May 9;56(9):3492-506
pubmed: 23547652
Blood. 1996 Sep 15;88(6):2236-40
pubmed: 8822944
J Biol Chem. 2002 Jul 12;277(28):25748-55
pubmed: 11948178
ChemMedChem. 2013 Feb;8(2):272-9
pubmed: 23292995
Cancer Manag Res. 2015 Jul 31;7:241-51
pubmed: 26346546
Biochem Biophys Res Commun. 2013 Jul 12;436(4):571-7
pubmed: 23727580
J Biol Chem. 2004 Mar 26;279(13):13224-33
pubmed: 14665640
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
J Med Chem. 2015 Mar 26;58(6):2809-20
pubmed: 25734520
J Med Chem. 2007 Jun 28;50(13):3054-61
pubmed: 17539623
Leukemia. 2007 Apr;21(4):833-5
pubmed: 17268511
Mol Cancer Res. 2013 Sep;11(9):1072-7
pubmed: 23723075
Nat Chem Biol. 2016 Sep;12(9):741-7
pubmed: 27454933
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13459-13464
pubmed: 29203661
Chin J Cancer. 2016 May 27;35:48
pubmed: 27233483
Int J Mol Sci. 2018 Aug 09;19(8):
pubmed: 30096875
J Biol Chem. 2015 May 15;290(20):12487-96
pubmed: 25770209
Bioorg Med Chem Lett. 2009 Jan 15;19(2):336-40
pubmed: 19084395
Nature. 1999 Sep 9;401(6749):188-93
pubmed: 10490031
J Med Chem. 2012 Nov 26;55(22):9891-9
pubmed: 23009203
Arch Iran Med. 2008 May;11(3):247-51
pubmed: 18426313
J Gen Virol. 2017 Mar;98(3):322-337
pubmed: 27959772
Trends Immunol. 2018 Aug;39(8):591-595
pubmed: 29937401
Leukemia. 2015 Sep;29(9):1939-42
pubmed: 25676420
Oncotarget. 2015 Jan 1;6(1):26-42
pubmed: 25622104
J Med Chem. 2016 Feb 25;59(4):1545-55
pubmed: 26653328
Bioorg Med Chem Lett. 2015 Oct 1;25(19):4320-4
pubmed: 26264503
J Med Chem. 2014 May 22;57(10):4009-22
pubmed: 24766560
J Biol Chem. 2018 Feb 9;293(6):1976-1993
pubmed: 29259132
Sci Signal. 2010 Sep 14;3(139):re6
pubmed: 20841568
Trends Pharmacol Sci. 2014 Oct;35(10):501-9
pubmed: 25234862
PLoS One. 2014 Mar 10;9(3):e90932
pubmed: 24614595
BMC Cancer. 2019 Aug 28;19(1):849
pubmed: 31462241
Proteomics. 2006 Aug;6(16):4554-64
pubmed: 16858728
Theranostics. 2016 Aug 12;6(11):1947-62
pubmed: 27570562
Cancer Res. 2003 Aug 15;63(16):5126-35
pubmed: 12941844
Genes Dev. 1998 May 15;12(10):1415-24
pubmed: 9585502
Leuk Lymphoma. 2011 Aug;52(8):1544-55
pubmed: 21699378
Clin Epigenetics. 2016 May 25;8:61
pubmed: 27226812
Mol Cell. 2014 Jul 3;55(1):31-46
pubmed: 24882211
J Clin Invest. 2017 Apr 3;127(4):1353-1369
pubmed: 28287402
Biol Open. 2014 May 02;3(6):418-30
pubmed: 24795145
Oncogene. 2001 Oct 1;20(44):6348-71
pubmed: 11607838
Leukemia. 2003 Feb;17(2):463-5
pubmed: 12592349
Chem Commun (Camb). 2019 Dec 5;55(98):14848-14851
pubmed: 31769449
Cancer Cell. 2012 Feb 14;21(2):266-81
pubmed: 22340598
J Biomol Struct Dyn. 2017 Oct;35(13):2794-2814
pubmed: 27589363
Mol Cell Biol. 2014 Apr;34(7):1188-97
pubmed: 24421390
ACS Cent Sci. 2017 Sep 27;3(9):1006-1014
pubmed: 28979942
Cell. 2002 Jul 26;110(2):163-75
pubmed: 12150925
Clin Cancer Res. 2006 Oct 1;12(19):5869-78
pubmed: 17020995
PLoS One. 2011;6(12):e28563
pubmed: 22174839
Clin Sci (Lond). 2016 Jun 1;130(12):987-1003
pubmed: 27154743
Biomaterials. 2015 May;51:208-215
pubmed: 25771011
Biochem Pharmacol. 2016 Jan 1;99:31-52
pubmed: 26549368
Leuk Res. 2010 Oct;34(10):1255-68
pubmed: 20537386
J Med Chem. 2008 Jun 26;51(12):3437-48
pubmed: 18494463
Ann Biol Clin (Paris). 2017 Apr 1;75(2):129-145
pubmed: 28377326
Cancer Cell. 2010 May 18;17(5):427-42
pubmed: 20478526
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15704-9
pubmed: 24023063
Blood. 2000 Feb 1;95(3):776-82
pubmed: 10648385
Hematology Am Soc Hematol Educ Program. 2009;:461-76
pubmed: 20008232
Clin Cancer Res. 2011 May 15;17(10):3219-32
pubmed: 21474579
J Med Chem. 2018 Sep 13;61(17):8054-8060
pubmed: 30118224
J Med Chem. 2018 Apr 26;61(8):3454-3477
pubmed: 29589441
Oncotarget. 2016 Aug 30;7(35):57117-57130
pubmed: 27494887
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
Blood Adv. 2018 Nov 13;2(21):3012-3024
pubmed: 30425065
Cancer Med. 2019 Sep;8(11):5173-5182
pubmed: 31350815
Leukemia. 2003 Oct;17(10):2054-5
pubmed: 14513059
Leukemia. 2015 Jun;29(6):1336-43
pubmed: 25783795
Org Lett. 2018 Jun 1;20(11):3255-3258
pubmed: 29790770
Nat Cell Biol. 2013 May;15(5):472-80
pubmed: 23604317
J Med Chem. 2009 Dec 10;52(23):7836-46
pubmed: 19705846
EMBO J. 2001 Dec 3;20(23):6793-804
pubmed: 11726515
Leuk Res. 2012 Aug;36(8):1055-62
pubmed: 22464548
Blood. 2008 Sep 1;112(5):1886-93
pubmed: 18591380
Org Biomol Chem. 2015 Oct 28;13(40):10226-35
pubmed: 26309122
J Med Chem. 2016 Feb 25;59(4):1455-70
pubmed: 26443078
J Biol Chem. 2008 Jul 25;283(30):21065-73
pubmed: 18499657
J Clin Invest. 2007 Aug;117(8):2033-5
pubmed: 17671636
J Med Chem. 2008 Aug 14;51(15):4370-3
pubmed: 18642892
Drug Discov Today Technol. 2014 Mar;11:89-99
pubmed: 24847658
Science. 1994 Oct 7;266(5182):129-33
pubmed: 7939633
J Exp Clin Cancer Res. 2016 Dec 5;35(1):182
pubmed: 27916001
J Med Chem. 2019 Sep 26;62(18):8557-8577
pubmed: 31414801
Eur J Pharmacol. 2018 Jun 5;828:67-79
pubmed: 29563065
Genes Cancer. 2012 May;3(5-6):436-46
pubmed: 23226581
Am J Physiol Cell Physiol. 2007 May;292(5):C1775-86
pubmed: 17229814
J Med Chem. 2018 Feb 8;61(3):905-917
pubmed: 29304284
J Biol Chem. 2013 Nov 15;288(46):33156-70
pubmed: 24089523
Leukemia. 2014 Mar;28(3):629-41
pubmed: 24263804
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):13162-13167
pubmed: 27799547
Ann N Y Acad Sci. 2003 Mar;983:84-100
pubmed: 12724214
Lancet. 2015 Apr 11;385(9976):1447-59
pubmed: 25484026
J Adv Pract Oncol. 2016 Mar;7(2):160-175
pubmed: 28090366
Adv Hematol. 2015;2015:612567
pubmed: 26843864
Acta Biochim Pol. 2013;60(4):503-14
pubmed: 24273759
Cancer Lett. 2017 Apr 10;391:162-171
pubmed: 28153791
PLoS One. 2013 Sep 27;8(9):e76016
pubmed: 24086678
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):283-294
pubmed: 28577984
ACS Chem Biol. 2012 Feb 17;7(2):331-9
pubmed: 22047054
Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3374-83
pubmed: 26080397
Elife. 2013 Dec 03;2:e01557
pubmed: 24302573
Biologics. 2016 Feb 26;10:23-31
pubmed: 27013862
Folia Med (Plovdiv). 2018 Dec 1;60(4):617-623
pubmed: 31188765
Oncotarget. 2014 Jul 30;5(14):5257-71
pubmed: 24913448
FEBS J. 2013 Feb;280(3):775-93
pubmed: 23181831
Mol Cell Biol. 2009 Apr;29(8):2068-81
pubmed: 19188443
Cell Death Dis. 2018 May 29;9(6):655
pubmed: 29844403
J Biol Chem. 2012 Aug 17;287(34):29168-74
pubmed: 22778253
EMBO J. 1994 Feb 15;13(4):764-73
pubmed: 8112292
Cell Death Discov. 2018 Sep 26;4:41
pubmed: 30302275
Drug Discov Today Technol. 2014 Mar;11:5-10
pubmed: 24847647
Exp Hematol. 2016 May;44(5):315-21
pubmed: 26923266
J Hematol Oncol. 2018 Sep 3;11(1):111
pubmed: 30176876
Nucleic Acids Res. 2015 Feb 27;43(4):2057-73
pubmed: 25662604
Blood. 2012 Mar 15;119(11):2579-89
pubmed: 22262760
Cancers (Basel). 2013 Jul 25;5(3):919-42
pubmed: 24202327
J Neurochem. 2009 Jun;109(6):1756-66
pubmed: 19457097
Br J Haematol. 2005 May;129(3):377-80
pubmed: 15842662
Stem Cells Transl Med. 2019 Aug;8(8):768-774
pubmed: 31016860
Crit Rev Oncol Hematol. 2015 Mar;93(3):277-92
pubmed: 25500000
Int J Mol Sci. 2013 May 02;14(5):9514-35
pubmed: 23644884
J Med Chem. 2020 Jan 9;63(1):23-39
pubmed: 31415174
Immunol Rev. 2009 Nov;232(1):273-85
pubmed: 19909370
Sci Rep. 2017 Jun 15;7(1):3571
pubmed: 28620171
Oncogene. 2018 Nov;37(45):5952-5966
pubmed: 29980788
Molecules. 2016 Nov 23;21(11):
pubmed: 27886118
Biochem Pharmacol. 2020 Mar;173:113698
pubmed: 31706847
Neuropsychopharmacology. 2014 Jan;39(2):389-400
pubmed: 23954848
Pharmacogenomics. 2018 Apr;19(5):475-393
pubmed: 29569526
J Med Chem. 2013 Sep 26;56(18):7201-11
pubmed: 23964961
Cancer Biol Ther. 2014 Jun 1;15(6):742-57
pubmed: 24618845
Sci Rep. 2018 Nov 23;8(1):17297
pubmed: 30470828
Cancer Res. 2001 Mar 15;61(6):2343-55
pubmed: 11289094
Mol Cancer Res. 2016 Oct;14(10):994-1008
pubmed: 27358110
J Med Chem. 2004 Oct 7;47(21):5235-43
pubmed: 15456267
J Hematol Oncol. 2018 Jun 20;11(1):84
pubmed: 29925402
Leukemia. 2017 Mar;31(3):593-601
pubmed: 27568522
Cancer Res. 2000 Feb 15;60(4):1097-103
pubmed: 10706130
Clin Cancer Res. 2011 Jan 15;17(2):212-21
pubmed: 21098337
Epigenomics. 2015;7(1):103-18
pubmed: 25687470
Front Oncol. 2019 Sep 24;9:939
pubmed: 31612105
Eur J Med Chem. 2018 Jan 1;143:1406-1418
pubmed: 29133060
ChemMedChem. 2009 Feb;4(2):283-90
pubmed: 19090524
Biochimie. 2009 Mar;91(3):320-8
pubmed: 19022332
Exp Cell Res. 2018 Sep 15;370(2):519-530
pubmed: 30017934
J Med Chem. 2007 Nov 1;50(22):5425-38
pubmed: 17929798
Biochem Biophys Res Commun. 2013 Nov 29;441(4):970-5
pubmed: 24220335

Auteurs

Hélène Losson (H)

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg 9, rue Edward Steichen, L2540 Luxembourg, Luxembourg.

Michael Schnekenburger (M)

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg 9, rue Edward Steichen, L2540 Luxembourg, Luxembourg.

Mario Dicato (M)

Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg 9, rue Edward Steichen, L2540 Luxembourg, Luxembourg.

Marc Diederich (M)

College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea.

Classifications MeSH